Open Access. Powered by Scholars. Published by Universities.®
- Institution
Articles 1 - 2 of 2
Full-Text Articles in Organisms
Streptococcus Cristatus – An Oral Bacterium Causing A Case Of Mild Bacteremia And “Possible Endocarditis”, Camilo Guzman, Adi Zaclli, John Molinari
Streptococcus Cristatus – An Oral Bacterium Causing A Case Of Mild Bacteremia And “Possible Endocarditis”, Camilo Guzman, Adi Zaclli, John Molinari
Medical Student Research Symposium
Streptococcus cristatus is a member of the Mitis streptococcus group. Like other members of this group, it resides in mucosal surfaces of the oral cavity but rarely causes disease. We present a case of S. cristatus bacteremia and “possible endocarditis” (per the modified Duke criteria) in a 59-year-old male suffering from end- stage cryptogenic cirrhosis. To date, it is the fifth reported case of disease caused by the microbe, and the first adult case in which S. cristatus was the sole microbe identified. Our patient had a history of dental caries and poor dentition, which were likely the source of …
Microbicidal Effects Of Α- And Θ-Defensins Against Antibiotic-Resistant Staphylococcus Aureus And Pseudomonas Aeruginosa, Kenneth P. Tai, Karishma Kamdar, Jason Yamaki, Valerie V. Le, Dat Tran, Patti Tran, Michael E. Selsted, Andre J. Ouelette, Annie Wong-Beringer
Microbicidal Effects Of Α- And Θ-Defensins Against Antibiotic-Resistant Staphylococcus Aureus And Pseudomonas Aeruginosa, Kenneth P. Tai, Karishma Kamdar, Jason Yamaki, Valerie V. Le, Dat Tran, Patti Tran, Michael E. Selsted, Andre J. Ouelette, Annie Wong-Beringer
Pharmacy Faculty Articles and Research
Antibiotic-resistant bacterial pathogens threaten public health. Because many antibiotics target specific bacterial enzymes or reactions, corresponding genes may mutate under selection and lead to antibiotic resistance. Accordingly, antimicrobials that selectively target overall microbial cell integrity may offer alternative approaches to therapeutic design. Naturally occurring mammalian α- and θ-defensins are potent, non-toxic microbicides that may be useful for treating infections by antibiotic-resistant pathogens because certain defensin peptides disrupt bacterial, but not mammalian, cell membranes. To test this concept, clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA), including vancomycin heteroresistant strains, and ciprofloxacin-resistant Pseudomonas aeruginosa (CipR-PA) were tested for sensitivity to …